Vanda Pharmaceuticals
Vanda Pharmaceuticals Logo
About Vanda Pharmaceuticals
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapies to address high unmet medical needs worldwide. Its marketed products include HETLIOZ for non-24-hour sleep-wake disorders, Fanapt (iloperidone) for bipolar I disorder and Parkinson's disease psychosis, and Ponvory for psoriasis and ulcerative colitis. The company's pipeline includes treatments for sleep disorders, schizophrenia, bipolar disorder, gastroparesis, motion sickness, atopic dermatitis, hematologic malignancies, performance anxiety, cystic fibrosis, dry eye, secretory diarrhea, Charcot-Marie-Tooth Disease, and polycythemia vera. Vanda Pharmaceuticals Inc. was founded in 2002 and is headquartered in Washington, D.C.
Address
2200 Pennsylvania Avenue NW, Suite 300E
Washington, 20037
United States
Year founded
2002
Number of employees
300-400
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
